<h1>Sun Pharma Advanced Research Announces Board Meeting to Approve Q1 Financial Results and Confirms Trading Window Closure</h1>
Sun Pharma Advanced Research Company Ltd has scheduled a meeting of its Board of Directors to review and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ending June 30, 2026. The Board meeting is set to be held on Monday, August 10, 2026.
In addition to the financial announcement, the company confirmed the closure of its trading window under the Code of Conduct.
The trading window for all Directors, Key Managerial Personnel (KMPs), Designated Employees, and Connected Persons has been closed as of July 01, 2026. The restricted period will remain in effect until the end of 48 hours following the declaration and submission of the Financial Results to Stock Exchanges.
SPARC Stock Price Movement
Today, shares of Sun Pharma Advanced Research Company Limited gained slightly in post-market trading, concluding at an indicative price of ₹207.93 after rising 0.87%. The stock traded a volume of 792,463 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.